- Home
- PTA vs AORT Comparison
PTA vs AORT Comparison
Compare PTA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTA | AORT |
|---|---|---|
| Founded | 2020 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.1B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | PTA | AORT |
|---|---|---|
| Price | $19.28 | $46.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.36 |
| AVG Volume (30 Days) | 159.2K | ★ 366.6K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $422,646,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | N/A | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $15.84 | $21.97 |
| 52 Week High | $19.67 | $48.25 |
Technical Indicators
Market Signals| Indicator | PTA | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.89 | 58.10 |
| Support Level | $19.21 | $45.41 |
| Resistance Level | $19.55 | $48.25 |
| Average True Range (ATR) | 0.15 | 1.41 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 28.95 | 75.58 |
Price Performance
Historical ComparisonAbout PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.